# ITM

全球领先的无载体镥-177供应商，与劳厄-朗之万研究所自2009年起开展Lu-177生产合作，并于2026年与Radiopharm Theranostics签署新的供应协议。

Source: https://cn.bioecon.ru/companies/itm/
Updated: 2026-07-03

- 国家: Germany

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 2024 年 €1.88 亿的风险投资轮 (2024-06-01) | https://www.globenewswire.com/en/news-release/2024/06/06/2894478/0/en/ITM-Raises-188m-to-Enhance-Radiopharmaceutical-Pipeline-and-to-Strengthen-Leading-Position-in-Medical-Radioisotope-Manufacturing.html |
| 生产基地 | 位于德国Neufahrn的NOVA设施（全球最大的Lu-177生产基地） (2024-01-04) | https://www.itm-radiopharma.com/news/press-releases/press-releases-detail/ITM_Announces_Operational_Readiness_for_NOVA_Facility,_the_Worlds_Largest_Lutetium-177_Production_Site-664/, https://www.itm-radiopharma.com/news/press-releases/press-releases-detail/itm-opens-worlds-largest-lutetium-177-production-facility-for-targeted-radionuclide-therapies-against-cancer-644/ |
| 生产基地 | IAZ 设施位于德国加兴（Garching） (2022-10-13) | https://www.biospace.com/itm-multiplies-production-capacity-for-its-n-c-a-lutetium-177 |
| 营收 | 2024年为$380 million (2024-12-31) [中等置信度] | https://compworth.com/company/itm-isotope-technologies-munich-se, https://www.privco.com/company/itm-isotope-technologies-munich-se |
| 监管批准 | NOVA工厂的放射性材料处理许可证(RAM License) (2024-01-04) | https://www.ans.org/news/article-5669/germanys-itm-receives-material-license-to-produce-lu177/, https://www.itm-radiopharma.com/news/press-releases/press-releases-detail/ITM_Announces_Operational_Readiness_for_NOVA_Facility,_the_Worlds_Largest_Lutetium-177_Production_Site-664/ |
| 认证 | 符合GMP标准(EndolucinBeta) (2023-01-01) | https://www.itm-radiopharma.com/radioisotopes/?open=c4682 |
| 产能 | 通过新的 IAZ 生产线大幅提升产能；NOVA 设施产能每年可服务多达数十万名患者 (2022-10-13) | https://www.biospace.com/itm-multiplies-production-capacity-for-its-n-c-a-lutetium-177 |

独立来源: ans.org, biospace.com, compworth.com, globenewswire.com, itm-radiopharma.com, privco.com

## 技术

- [放射性药物与诊疗一体化](https://cn.bioecon.ru/technology/radiopharmaceuticals-theranostics/)